Prenetics Global is trading at $21.80, up 6.86%, with no clear company-specific announcement identified to explain the October 7 rise.
- Its investor-relations page showed no release newer than October 2. The gain came amid a broader market decline, which does not explain the move.
- The October 6 report also noted no direct cause for that sessionβs decline. Trading volume data was unavailable, so activity relative to normal levels cannot be assessed.